<bill session="103" type="s" number="1753" updated="2012-07-17T05:46:44-04:00">
	<state datetime="1993-11-20">REFERRED</state>
	<status><introduced datetime="1993-11-20"/></status>

	<introduced datetime="1993-11-20"/>
	<titles>
		<title type="official" as="introduced">A bill amending the Harmonized Tariff Schedule.</title>
	</titles>
	<sponsor id="401709"/>
	<cosponsors>
		<cosponsor id="300064" joined="1993-11-20"/>
	</cosponsors>
	<actions>
		<action datetime="1993-11-20" state="INTRODUCED"><text>Sponsor introductory remarks on measure. (CR S16768)</text></action>
		<action datetime="1993-11-20" state="REFERRED"><text>Read twice and referred to the Committee on Finance.</text></action>
	</actions>
	<committees>
		<committee code="SSFI" name="Senate Finance" activity="Referral, In Committee" />
	</committees>
	<relatedbills>
		<bill relation="identical" session="103" type="h" number="3174" />
	</relatedbills>
	<subjects>
		<term name="Foreign trade and international finance"/>
		<term name="Chemicals"/>
		<term name="Drugs"/>
		<term name="Tariff"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	11/20/1993--Introduced.
Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 1996, the duty on N-(1,1-dimethylethyl- 3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide (finasteride and finasteride tablets).

	</summary>
</bill>
